Context Therapeutics Inc. (CNTX) vs OneMedNet Corporation (ONMD)

A side-by-side comparison of Context Therapeutics Inc. and OneMedNet Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CNTX

Context Therapeutics Inc.

$30M

$0.32HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT

ONMD

OneMedNet Corporation

$29M

$5.07HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT

Total return — CNTX vs ONMD

growth of $100 · dividends reinvested · last 5y

CNTX -93.4% (-41.9%/yr)ONMD -94.9% (-44.9%/yr)CNTX compounded faster over this window

CNTX ONMD

CNTX vs ONMD: by the numbers

•CNTX is the larger company ($30M vs $29M market cap).
•Both run net losses; CNTX's is the smaller (0.00% vs -584.20% net margin).

Metrics side by side

Valuation

Metric	CNTX	ONMD
P/S ratio	N/A	19.83
P/B ratio	0.78	N/A

Profitability

Metric	CNTX	ONMD
Gross margin	0.00%	-37.01%
Operating margin	0.00%	-711.33%
Net margin	0.00%	-584.20%
ROE	-120.40%	N/A
ROIC	-126.84%	N/A

Growth (annualized)

Metric	CNTX	ONMD
Revenue CAGR (5Y)	N/A	10.53%
Total return CAGR (5Y)	N/A	-44.89%

Go deeper

Full CNTX analysis Full ONMD analysis Interactive comparison tool

Dig into the metrics

Context Therapeutics ROE OneMedNet ROE Context Therapeutics operating margin OneMedNet operating margin Context Therapeutics revenue growth OneMedNet revenue growth Context Therapeutics free cash flow OneMedNet free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.